Companies that own Ardelyx Inc.
Adage Capital Management LP
3,500,000
5.64%
500,000
0.03%
07/13/2018
Deerfield Management Company LP
3,491,922
5.63%
889,189
0.43%
06/30/2018
Future Fund Management Agency
3,436,426
5.54%
0
5.23%
04/20/2018
BlackRock Fund Advisors
3,206,850
5.17%
828,109
0%
06/30/2018
Rock Springs Capital Management LP
2,525,557
4.07%
250,000
0.4%
06/30/2018
The Vanguard Group, Inc.
1,893,880
3.05%
439,151
0%
06/30/2018
Dimensional Fund Advisors LP
1,292,681
2.08%
365,392
0%
06/30/2018
Millennium Management LLC
1,083,199
1.75%
658,688
0.01%
06/30/2018
Marshall Wace North America LP
1,068,606
1.72%
-104,856
0.03%
06/30/2018
Renaissance Technologies LLC
775,140
1.25%
383,340
0%
06/30/2018
| Address |
34175 Ardenwood Boulevard
Fremont California 94555
United States
|
|
Employees
|
- |
| Website |
http://www.ardelyx.com |
| Updated |
07/08/2019 |
| Ardelyx, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicine for the treatment of renal diseases. It also focuses on the development of programs directed toward treating gastrointestinal and irritable bowel syndrome with constipations. Its product portfolio includes tenapanor, which is an experimental medication that works exclusively in the gut and is in late-stage clinical development. |
